- Home
- SPNS vs SLNO Comparison
SPNS vs SLNO Comparison
Compare SPNS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- SLNO
- Stock Information
- Founded
- SPNS 1982
- SLNO 1999
- Country
- SPNS Israel
- SLNO United States
- Employees
- SPNS N/A
- SLNO N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SPNS Technology
- SLNO Health Care
- Exchange
- SPNS Nasdaq
- SLNO Nasdaq
- Market Cap
- SPNS 1.6B
- SLNO 3.8B
- IPO Year
- SPNS 1992
- SLNO 2014
- Fundamental
- Price
- SPNS $29.13
- SLNO $86.14
- Analyst Decision
- SPNS Buy
- SLNO Strong Buy
- Analyst Count
- SPNS 4
- SLNO 9
- Target Price
- SPNS $34.25
- SLNO $103.33
- AVG Volume (30 Days)
- SPNS 138.7K
- SLNO 1.0M
- Earning Date
- SPNS 07-31-2025
- SLNO 08-06-2025
- Dividend Yield
- SPNS 2.09%
- SLNO N/A
- EPS Growth
- SPNS 11.11
- SLNO N/A
- EPS
- SPNS 1.30
- SLNO N/A
- Revenue
- SPNS $544,235,000.00
- SLNO N/A
- Revenue This Year
- SPNS $8.30
- SLNO N/A
- Revenue Next Year
- SPNS $7.42
- SLNO N/A
- P/E Ratio
- SPNS $22.12
- SLNO N/A
- Revenue Growth
- SPNS 3.84
- SLNO N/A
- 52 Week Low
- SPNS $23.69
- SLNO $39.41
- 52 Week High
- SPNS $41.22
- SLNO $86.79
- Technical
- Relative Strength Index (RSI)
- SPNS 51.33
- SLNO 62.72
- Support Level
- SPNS $28.44
- SLNO $78.48
- Resistance Level
- SPNS $29.56
- SLNO $86.67
- Average True Range (ATR)
- SPNS 0.58
- SLNO 2.78
- MACD
- SPNS -0.05
- SLNO 0.40
- Stochastic Oscillator
- SPNS 35.77
- SLNO 67.95
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.